These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16822381)

  • 61. [Rosacea fulminans: report of two cases].
    Sanz-Motilva V; Martorell Calatayud A; Rivera R; Vanaclocha-Sebastián F
    Rev Med Chil; 2012 May; 140(5):637-9. PubMed ID: 23096671
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Steroid-induced periorificial dermatitis in children--clinical features and response to azelaic acid.
    Jansen T; Melnik BC; Schadendorf D
    Pediatr Dermatol; 2010; 27(2):137-42. PubMed ID: 19804495
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Naphthalene in the treatment of patients with atopic dermatitis.
    Smeh-Skrbin A; Dobrić I; Krnjević-Pezić G; Vrzogić P
    Acta Dermatovenerol Croat; 2007; 15(1):15-9. PubMed ID: 17433174
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Crisaborole: A new and effective nonsteroidal topical drug for atopic dermatitis.
    Kailas A
    Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28834023
    [No Abstract]   [Full Text] [Related]  

  • 65. StabiEL: stabilization of skin condition with Elidel--a patients' satisfaction observational study addressing the treatment, with pimecrolimus cream, of atopic dermatitis pretreated with topical corticosteroid.
    Gollnick H; Luger T; Freytag S; Bräutigam M;
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1319-25. PubMed ID: 18540990
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: an 8-week split-face clinical trial.
    Lee DH; Li K; Suh DH
    Br J Dermatol; 2008 May; 158(5):1069-76. PubMed ID: 18363758
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
    Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Present and future rosacea therapy.
    Wolf JE
    Cutis; 2005 Mar; 75(3 Suppl):4-7; discussion 33-6. PubMed ID: 15810803
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
    Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rosacea fulminans.
    Ribeiro LB; Ramos-e-Silva M
    Cutis; 2013 Jul; 92(1):29-32. PubMed ID: 23961522
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Use of pimecrolimus cream in disorders other than atopic dermatitis.
    Day I; Lin AN
    J Cutan Med Surg; 2008; 12(1):17-26. PubMed ID: 18258153
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Azelaic acid 15% gel in the treatment of rosacea.
    Gollnick H; Layton A
    Expert Opin Pharmacother; 2008 Oct; 9(15):2699-706. PubMed ID: 18803456
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Ocular rosacea].
    Sobolewska B; Zierhut M
    Hautarzt; 2013 Jul; 64(7):506-8. PubMed ID: 23824155
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Case studies.
    Bikowski JB
    Cutis; 2006 Feb; 77(2 Suppl):17-21. PubMed ID: 16566284
    [No Abstract]   [Full Text] [Related]  

  • 76. Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study.
    Guttman-Yassky E; Silverberg JI; Nemoto O; Forman SB; Wilke A; Prescilla R; de la Peña A; Nunes FP; Janes J; Gamalo M; Donley D; Paik J; DeLozier AM; Nickoloff BJ; Simpson EL
    J Am Acad Dermatol; 2019 Apr; 80(4):913-921.e9. PubMed ID: 29410014
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Tailored Approach to the Treatment of a Patient with a Severe Dynamic Manifestation of Rosacea: A Case Report.
    Schaller M; Gonser L
    Drugs R D; 2016 Sep; 16(3):279-283. PubMed ID: 27623792
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Safety and efficacy of fluticasone propionate in the topical treatment of skin diseases.
    Roeder A; Schaller M; Schäfer-Korting M; Korting HC
    Skin Pharmacol Physiol; 2005; 18(1):3-11. PubMed ID: 15608497
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [The therapeutic activity of Cutivate in the treatment of inflammatory skin diseases].
    Trubin VP; Dubinin VP; Glad'ko OV; Volkova OA
    Voen Med Zh; 2000 Mar; 321(3):36-8. PubMed ID: 10815538
    [No Abstract]   [Full Text] [Related]  

  • 80. Immunologic Targets in Atopic Dermatitis and Emerging Therapies: An Update.
    Wang D; Beck LA
    Am J Clin Dermatol; 2016 Oct; 17(5):425-443. PubMed ID: 27371134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.